Categories: CancerNews

Mammolink Launches 5th Mobile Mammography Bus Powered by RamSoft® Cloud-Based PACS

RamSoft’s Flexible Software Platform has enabled Mammolink to Operationalize Complex Imaging Workflows and Scale their Growing Mobile Business

TORONTO and TAMPA, Fla., Aug. 22, 2024 /PRNewswire/ – RamSoft®, a global leader in cloud-based RIS/PACS radiology solutions for imaging centers and providers, announces that Mammolink, a leading provider of 3D mammography and diagnostic ultrasound imaging services, has launched its 5th mobile mammography bus powered by RamSoft’s cloud-based PACS software. Mammolink provides its imaging services across Florida in state-of-the-art buses outfitted with the latest in 3D mammography imaging. The buses use RamSoft’s PACS and Gateway routers to allow fast, secure management and transfer of large radiological data sets from the remote buses to a central reading location. RamSoft also provides the viewing and analysis tools for radiologists and a communication portal with which patients can access their results and communicate with Mammolink to schedule follow-ups.

“We started Mammolink to reimagine women’s health and to make getting regular mammograms much more accessible and convenient”, says Dr. Ryan Polselli, Co-Founder of Mammolink and Radiologist. “The other part of the equation is guaranteeing turnaround times of 24 hours or less because waiting for your results is extremely stressful. Using RamSoft’s cloud-based software solutions allows us to meet our service standard”.

“We perform our 3D mammograms in our specialized buses that move daily to different locations across Florida“, says Miranda Polselli, co-founder of Mammolink and Chief Operating Officer. “We quickly upload large 3D data sets from the busses knowing the data is safe and secure. We then read the images and provide reports and updates within 24 hours. This complex functionality is delivered by RamSoft and is helping us scale our business”.

“We really value working with Mammolink and appreciate that they have trusted us to help them scale their mobile imaging operations,” stated Vijay Ramanathan, CEO and co-founder of RamSoft. “We pride ourselves on our flexible software and modular design so that radiologists and imaging centers use the tools they need and can expand their infrastructure and grow profitably. .”

About RamSoft®

RamSoft is a global provider of innovative cloud-based radiology software solutions for imaging centers, radiology departments, and teleradiology providers. PowerServer, utilized by over 500 sites and thousands of customers worldwide, offers a flexible, scalable design enabling imaging operations of all sizes to leverage comprehensive cloud-based RIS (Radiology Information System)/PACS (Picture Archiving and Communication System) capabilities. RamSoft’s latest offering, OmegaAI®, is a cloud-native AI-driven platform delivering rapid, secure, and robust RIS and PACS capabilities that are completely zero footprint, powered by Microsoft Azure. Additionally, Blume – Patient Portal allows patients to access, store and share their diagnostic imaging studies with referring physicians, family members and for personal record.

About Mammolink

MammoLink® is improving breast cancer screening by changing the relationship between doctors, radiologists, and patients to make mammograms more accessible. Operating 5 state-of-the-art mobile mammography buses, Mammolink provides accessible 3D mammography to women across Florida with guaranteed results provided within 24 hours. For more information, please visit www.3DMobilemammography.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/mammolink-launches-5th-mobile-mammography-bus-powered-by-ramsoft-cloud-based-pacs-302228143.html

SOURCE RamSoft Inc.

Staff

Recent Posts

George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at ESC Congress 2024

George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension…

7 hours ago

Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates

SHANGHAI, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX:…

7 hours ago

Avricore Grants Options

VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the…

7 hours ago

Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to October 3, 2024

NEW YORK, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC,…

7 hours ago

Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib

Proceeds to be used for development of lead compound tuspetinib in combination therapy as frontline…

7 hours ago

Jushi Holdings Inc. Announces Filing of Canadian Preliminary Base Shelf Prospectus

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…

7 hours ago